|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash | ||||||
| Prepaid expenses and other current assets | ||||||
| Total Current Assets | ||||||
| Marketable securities held in Trust Account | ||||||
| Total Assets | ||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||
| Current liabilities – Accrued expenses | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued expenses | ||||||
| Deferred underwriting fee payable | ||||||
| Advance from related party | ||||||
| Total Current Liabilities | ||||||
| Deferred underwriting fee payable | ||||||
| Warrant liabilities | ||||||
| Total Liabilities | ||||||
| Ordinary shares subject to possible redemption, 27,484,224 shares at redemption value | ||||||
| Class A ordinary shares subject to possible redemption, 20,403,682 and 23,470,955 shares at redemption value at March 31, 2021 and December 31, 2020 | ||||||
| Shareholders’ Equity | ||||||
| Common stock, value | ||||||
| Class A Ordinary Shares | ||||||
| Class B Ordinary Shares | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Shareholders’ Equity | ||||||
| Class A Ordinary Shares | ||||||
| Class B Ordinary Shares | ||||||
| Total Shareholders’ Equity | ||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
Loading...
